AMZN vs. LLY: Amazon.com vs. Eli Lilly Stock Comparison
This page compares Amazon.com (AMZN) with Eli Lilly (LLY) using performance and risk, profitability, financial strength, growth, dividends, and valuation metrics.
Performance
Cumulative Growth
Trailing Returns
Performance at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| 1-Year Return | 11.87% | 40.51% |
Risk
Drawdown
Amazon.com (AMZN) has an aggressive beta of 1.47, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.51 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
Risk at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| 1-Year Volatility | 30.20% | 38.09% |
| Beta | 1.47 | 0.51 |
| 3-Month Avg. Volume | 44.54M | 3.19M |
Company Profile
Amazon.com (AMZN) is classified in the Consumer Discretionary sector (Consumer Discretionary Distribution & Retail), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AMZN | LLY |
|---|---|---|
| Name | Amazon.com, Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Consumer Discretionary | Health Care |
| GICS Industry Group | Consumer Discretionary Distribution & Retail | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Broadline Retail | Pharmaceuticals |
| GICS Sub-Industry | Broadline Retail | Pharmaceuticals |
| Market Capitalization | 2,566.11 billion USD | 1,010.34 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | May 15, 1997 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Valuation
Price-to-Earnings Ratio (TTM)
Both Amazon.com (AMZN) at 31.64 and Eli Lilly (LLY) at 40.32 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AMZN
Consumer Discretionary Distribution & Retail industry group
31.64
- Max
- 54.29
- AMZN
- 31.64
- Q3
- 31.64
- Median
- 20.61
- Q1
- 12.78
- Min
- 1.13
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.32
- Max
- 77.14
- Q3
- 43.78
- LLY
- 40.32
- Median
- 24.68
- Q1
- 15.27
- Min
- 1.70
Price-to-Sales Ratio (TTM)
Eli Lilly (LLY) at 13.98 is priced about in line with its industry on P/S ratio, while Amazon.com (AMZN) at 3.45 sits in the pricier quartile — AMZN costs more per dollar of sales.
AMZN
Consumer Discretionary Distribution & Retail industry group
3.45
- Max
- 3.65
- AMZN
- 3.45
- Q3
- 1.78
- Median
- 0.73
- Q1
- 0.28
- Min
- 0.03
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.98
- Max
- 55.38
- Q3
- 24.42
- LLY
- 13.98
- Median
- 6.98
- Q1
- 3.30
- Min
- 0.01
Price-to-Book Ratio (MRQ)
Both look rich against book: Amazon.com (AMZN) at 5.81 sits in the upper P/B ratio quartile, and Eli Lilly (LLY) at 32.45 prices even higher, above its industry range.
AMZN
Consumer Discretionary Distribution & Retail industry group
5.81
- Max
- 11.07
- AMZN
- 5.81
- Q3
- 5.11
- Median
- 2.24
- Q1
- 1.05
- Min
- -3.64
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
32.45
- LLY
- 32.45
- Max
- 13.23
- Q3
- 6.38
- Median
- 3.46
- Q1
- 1.64
- Min
- -5.17
Valuation at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 31.64 | 40.32 |
| Price-to-Sales Ratio (TTM) | 3.45 | 13.98 |
| Price-to-Book Ratio (MRQ) | 5.81 | 32.45 |
| Free Cash Flow Yield | 0.38% | 0.91% |
Profitability
Return on Equity (TTM)
Eli Lilly (LLY) at 107.46% clears its industry range for ROE, a sharper capital-efficiency signal than Amazon.com (AMZN) at 24.29%, which is closer to a typical peer reading.
AMZN
Consumer Discretionary Distribution & Retail industry group
24.29%
- Max
- 63.82%
- Q3
- 31.67%
- AMZN
- 24.29%
- Median
- 12.96%
- Q1
- 4.89%
- Min
- -29.94%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
107.46%
- LLY
- 107.46%
- Max
- 101.32%
- Q3
- 2.92%
- Median
- -31.26%
- Q1
- -62.68%
- Min
- -158.89%
Net Profit Margin (TTM)
Eli Lilly (LLY) at 34.99% keeps the most of each sales dollar — above its industry’s net margin range — and Amazon.com (AMZN) at 12.22% also retains a top-quartile share.
AMZN
Consumer Discretionary Distribution & Retail industry group
12.22%
- Max
- 20.45%
- AMZN
- 12.22%
- Q3
- 8.75%
- Median
- 3.25%
- Q1
- 0.49%
- Min
- -11.15%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
34.99%
- LLY
- 34.99%
- Max
- 12.76%
- Q3
- 4.00%
- Median
- 0.00%
- Q1
- -2.26%
- Min
- -11.53%
Operating Profit Margin (TTM)
Both Amazon.com (AMZN) at 13.14% and Eli Lilly (LLY) at 49.39% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AMZN
Consumer Discretionary Distribution & Retail industry group
13.14%
- Max
- 23.15%
- AMZN
- 13.14%
- Q3
- 11.08%
- Median
- 4.61%
- Q1
- 1.68%
- Min
- -8.71%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
49.39%
- Max
- 100.30%
- LLY
- 49.39%
- Q3
- 4.40%
- Median
- 0.00%
- Q1
- -131.52%
- Min
- -333.43%
Profitability at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| Return on Equity (TTM) | 24.29% | 107.46% |
| Return on Assets (TTM) | 6.85% | 20.74% |
| Net Profit Margin (TTM) | 12.22% | 34.99% |
| Operating Profit Margin (TTM) | 13.14% | 49.39% |
| Gross Profit Margin (TTM) | 50.60% | 82.83% |
Growth
Revenue Growth
Revenue Growth at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| 1-Year Revenue Growth | 12.38% | 44.70% |
| 3-Year Revenue CAGR | 11.73% | 31.69% |
EPS Growth
EPS Growth at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| 1-Year EPS Growth | 29.66% | 95.99% |
| 3-Year EPS CAGR | -- | 51.71% |
Financial Strength
Current Ratio (MRQ)
Amazon.com (AMZN) at 1.18 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.50 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
AMZN
Consumer Discretionary Distribution & Retail industry group
1.18
- Max
- 2.97
- Q3
- 1.87
- Median
- 1.38
- AMZN
- 1.18
- Q1
- 1.03
- Min
- 0.46
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.50
- Max
- 24.81
- Q3
- 11.75
- Median
- 5.57
- Q1
- 2.69
- LLY
- 1.50
- Min
- 0.23
Debt-to-Equity Ratio (MRQ)
Amazon.com (AMZN) at 0.53 keeps leverage in the lower quartile, while Eli Lilly (LLY) at 1.39 sits in the higher-leverage quartile.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.53
- Max
- 3.27
- Q3
- 1.82
- Median
- 1.09
- Q1
- 0.67
- AMZN
- 0.53
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 1.60
- LLY
- 1.39
- Q3
- 0.68
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.18 | 1.50 |
| Debt-to-Equity Ratio (MRQ) | 0.53 | 1.39 |
| Net Debt / EBITDA | 0.59 | 1.05 |
Dividends
Dividend Yield (TTM)
Amazon.com (AMZN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a yield of 0.61%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 6.62%
- Q3
- 2.66%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.61%
- LLY
- 0.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Amazon.com (AMZN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a payout of 22.13%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 78.51%
- Q3
- 33.46%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
22.13%
- LLY
- 22.13%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividends at a Glance
| Metric | AMZN | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.61% |
| Dividend Payout Ratio (TTM) | 0.00% | 22.13% |